Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators

References

• eTG Complete. Schizoprenia and related psychoses. 2017. https://tgldcdp.tg.org.au/viewTopic?topicfile=schizophrenia-and-related-psychoses&guidelineName=Psychotropic#toc_d1e1269. Accessed 9 Feb 2018.
   Google Scholar
• Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990—2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2163–96. https://doi.org/10.1016/S0140-6736(12)61729-2.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Schizophrenia. 2016. http://www.who.int/mental_health/management/schizophrenia/en/. Accessed 9 Feb 2018.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Treatment and care for adults with psychosis or schizophrenia. 2017. https://pathways.nice.org.uk/pathways/psychosis-and-schizophrenia#path=view%3A/pathways/psychosis-and-schizophrenia/treatment-and-care-for-adults-with-psychosis-or-schizophrenia.xml&content=view-index. Accessed 9 Feb 2018.
   Google Scholar
• Warnez S and Alessi-Severini S. Clozapine: a review of clinical practice guidelines and prescribing trends. BMC Psychiatry 2014;14(1):102. 10.1186/1471-244X-14-102.
   Google Scholar
• Conley RR, Buchanan RW. Evaluation of treatment-resistant schizophrenia. Schizophr Bull. 1997;23(4):663–74. https://doi.org/10.1093/schbul/23.4.663.
   PubMed Web of Science ®Google Scholar
• Queensland Psychotrophic Medication Advisory Committee. Safe and quality use of clozapine therapy in mental health services. 2016. https://www.health.qld.gov.au/__data/assets/pdf_file/0025/625354/qh-gdl-437.pdf. Accessed 9 Feb 2018.
   Google Scholar
• Kar N, Barreto S, Chandavarkar R. Clozapine monitoring in clinical practice: beyond the mandatory requirement. Clin Psychopharmacol Neurosci. 2016;14(4):323–9. https://doi.org/10.9758/cpn.2016.14.4.323.
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620–627. https://doi.org/10.1016/S0140-6736(09)60742-X.
   PubMed Web of Science ®Google Scholar
• Sernyak MJ, Rosenheck RA. Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006. Psychiatr Serv. 2008;59(5):567–569. https://doi.org/10.1176/ps.2008.59.5.567.
   PubMed Web of Science ®Google Scholar
• Tang Y, Mao P-X, Jiang F, Chen Q, Wang C-Y, Cai Z-J, et al. Clozapine in China. Pharmacopsychiatry. 2008;41(01):1–9. https://doi.org/10.1055/s-2007-993224.
   PubMedGoogle Scholar
• Forrester T, Siskind D, Winckel K, Wheeler A, Hollingworth S. Increasing clozapine dispensing trends in Queensland, Australia 2004-2013. Pharmacopsychiatry. 2015;48(4—5):164–169. https://doi.org/10.1055/s-0035-1554713.
   PubMed Web of Science ®Google Scholar
• Malalagama G, Bastiampillai T, Dhillon R. Clozapine prescription patterns in Australia over the last 10 years. Aust N Z J Psychiatry. 2011;45(6):498–499. https://doi.org/10.3109/00048674.2011.561482.
   PubMed Web of Science ®Google Scholar
• Nielsen J, Young C, Ifteni P, Kishimoto T, Xiang Y-T, Schulte PF, et al. Worldwide differences in regulations of clozapine use. CNS Drugs. 2016;30(2):149. https://doi.org/10.1007/s40263-016-0311-1.
   PubMed Web of Science ®Google Scholar
• Filia SL, Wheelhouse A, Lee SJ, Main M, de Castella A, Wilkins S, et al. Transitioning patients taking clozapine from the public to private/GP shared-care setting: barriers and criteria. Aust N Z J Psychiatry. 2012;46(3):225–231. https://doi.org/10.1177/0004867411433210.
   PubMed Web of Science ®Google Scholar
• The Australian Government Department of Health. Pharmaceutical Benefits Scheme (PBS): New options for clozapine maintenance supply. The Australian Government Department of Health. 2015. https://www.pbs.gov.au/general/changes-to-certain-s100-programs/faqs-hsd-ca-clozapine-25-june-2015.pdf Accessed 20 Nov 2018.
   Google Scholar
• Sav A, King MA, Whitty JA, Kendall E, McMillan SS, Kelly F, et al. Burden of treatment for chronic illness: a concept analysis and review of the literature. Health Expect. 2015;18(3):312–324. https://doi.org/10.1111/hex.12046.
   PubMed Web of Science ®Google Scholar
• Tran V. Burden of treatment: the work of being a patient. 2015. https://minimallydisruptivemedicine.org/2015/06/29/burden-of-treatment-the-work-of-being-a-patient/. Accessed 9 Feb 2018.
   Google Scholar
• Murphy Kate, Coombes Ian, McMillan Sara, Wheeler Amanda. Clozapine and shared care: the consumer experience. Australian Journal Primary Health. 2018. https://doi.org/10.1071/PY18055.
   Web of Science ®Google Scholar
• Bjorksten C. The impact of new PBS listings for clozapine perspective of the senior HNE mental Health pharmacist at the mater campus in Newcastle. Society of Hospital Pharmacists of Austalia Bulletin. 2015:22.
   Google Scholar
• Commonwealth of Australia. Review of pharmacy remuneration and regulation final report. 2017. http://www.health.gov.au/internet/main/publishing.nsf/content/7E5846EB2D7BA299CA257F5C007C0E21/$File/review-of-pharmacy-remuneration-and-regulation-final-report.pdf. Accessed 22 Nov 2018.
   Google Scholar
• Pharmacy Board of Australia. Pharmacy Board of Australia Registrant Data. 2018. https://www.pharmacyboard.gov.au/about/statistics.aspx. Accessed 22 Nov 2018.
   Google Scholar
• Australian Government Department of Health. Senate inquiry on the effect of red tape on pharmacy rules. 2017. https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Red_Tape/Pharmacyrules. Accessed 22 Nov 2018.
   Google Scholar
• The Pharmacy Guild of Australia. Community pharmacies - a health care hub. 2018. https://www.guild.org.au/about-us/supporting-community-pharmacies Accessed 22 Nov 2018.
   Google Scholar
• Gan Yuh-Lin, O’Reilly Claire L. Community pharmacists’ attitudes and opinions towards supplying clozapine. International Journal Clinical Pharmacy. 2018. https://doi.org/10.1007/s11096-018-0676-y.
   PubMedGoogle Scholar
• Chaar BB, Wang H, Day CA, Hanrahan JR, Winstock AR, Fois R. Factors influencing pharmacy services in opioid substitution treatment. Drug Alcohol Rev. 2013;32(4):426–434. https://doi.org/10.1111/dar.12032.
   PubMed Web of Science ®Google Scholar
• Treloar C, Newland J, Rance J, Hopwood M. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. J Viral Hepat. 2010;17(12):839–844. https://doi.org/10.1111/j.1365-2893.2009.01250.x.
   PubMed Web of Science ®Google Scholar
• The Pharmacy Guild of Australia. Find a pharmacy. 2017. https://www.findapharmacy.com.au/home Accessed 28 Nov 2018.
   Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
   Google Scholar
• Queensland Parliament. Health, communities, disability services and domestic and family violence prevention commitee. Inquiry into the establishment of a pharmacy council and pharmacy ownership in Queensland. 2018. https://www.parliament.qld.gov.au/Documents/TableOffice/TabledPapers/2018/5618T747.pdf. Accessed 23 May 2019.
   Google Scholar
• Pharmacy Council of New South Wales. 2018. https://www.registersearch.net/v2/search.php Accessed 22 Nov 2018.
   Google Scholar
• Australian Government Department of Health and Sixth Community Pharmacy Agreement. MedsCheck and Diabetes MedsCheck. 2015. http://6cpa.com.au/medication-management-programs/medscheck-diabetes-medscheck/ Accessed 22 Nov 2018.
   Google Scholar
• Australian Government Department of Health. Section 100 - High Specialised Drugs Program https://www.pbs.gov.au/browse/section100-ca Accessed 22 Nov 2018.
   Google Scholar
• Australian Government Department of Health. Supply of clozapine in community settings (prescribing and dispensing maintenance therapy only) implementation issues. 2015. http://nswtag.gradestage.com/wp-content/uploads/2017/09/tga-clozapine-feb-2015.pdf Accessed 22 Nov 2018.
   Google Scholar
• Australian Bureau of Statistics. Regional population growth. Australia. 2017:2016.
   Google Scholar
• Knowles SA, McMillan S, Murphy K, Wheeler A. Providing clozapine in community pharmacy. Australian Pharmacist. 2016;35(1):56–60.
   Google Scholar
• Knowles SA, McMillan SS, Wheeler AJ. Consumer access to clozapine in Australia: how does this compare to New Zealand and the United Kingdom? Pharm Pract. 2016;14(2):722. https://doi.org/10.18549/PharmPract.2016.02.722.
   PubMedGoogle Scholar
• Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract. 2010;8(1):35.
   PubMedGoogle Scholar
• Brazinha I, Fernandez-Llimos F. Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals. Int J Clin Pharm. 2014;36(5):1031–1038. https://doi.org/10.1007/s11096-014-9991-0.
   PubMed Web of Science ®Google Scholar
• Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–230. https://doi.org/10.1023/A:1021526425458.
   PubMedGoogle Scholar
• MacIntosh C, Weiser C, Wassimi A, Reddick J, Scovis N, Guy M, et al. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists. J Am Pharm Assoc. 2009;49(1):26–30. https://doi.org/10.1331/JAPhA.2009.07122.
   Google Scholar
• Gastelurrutia MA, Fernández Llimós F, Garcia Delgado P, Gastelurrutia P, Faus MJ, Benrimoj SI. Barriers and facilitators to the dissemination and implementation of cognitive services in Spanish community pharmacies. Pharm Pract. 2005;3(2).
   Google Scholar
• Mansoor SM, Aslani P, Krass I. Pharmacists’ attitudes and perceived barriers to provision of adherence support in Australia. Int J Clin Pharm. 2014;36(1):136–144. https://doi.org/10.1007/s11096-013-9840-6.
   PubMed Web of Science ®Google Scholar
• Berbatis Constantine G, Sunderland V Bruce, Joyce Andrew, Bulsara Max, Mills Christina. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s National Pharmacy Database Project. International Journal Pharmacy Practice. 2007;15(3):185–191. 10.1211/ijpp.15.3.0005
   Google Scholar
• Beshir SA, Hanipah MA. Knowledge, perception, practice and barriers of breast cancer health promotion activities among community pharmacists in two districts of Selangor state, Malaysia. Asian Pac J Cancer Prev. 2012;13(9):4427–4430.
   PubMedGoogle Scholar
• Hossain LN, Fernandez-Llimos F, Luckett T, Moullin JC, Durks D, Franco-Trigo L, et al. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open. 2017;7(9):e015471. https://doi.org/10.1136/bmjopen-2016-015471.
   Web of Science ®Google Scholar
• Murphy Kate, Coombes Ian, Moudgil Vikas, Patterson Susan, Wheeler Amanda. Clozapine and concomitant medications: Assessing the completeness and accuracy of medication records for people prescribed clozapine under shared care arrangements. Journal Evaluation in Clinical Practice. 2017. https://doi.org/10.1111/jep.12743.
   PubMed Web of Science ®Google Scholar
• NHS Southern Health NHS Foundation Trust. Clozapine Guidelines. 2018. http://www.southernhealth.nhs.uk/EasysiteWeb/getresource.axd?AssetID=77706&type=full&servicetype=Inline Accessed 20 Nov 2018.
   Google Scholar
• DHBs Community Pharmacy Services Programme and Central Region Technical Advisory Services Limited. Protocol for the Dispensing of Clozapine by Community Pharmacies 2018. https://tas.health.nz/assets/Uploads/Clozapine-Dispensing-Protocols-Effective-1-October-2018.pdf Accessed 20 Nov 2018.
   Google Scholar
• SA Health. Clozapine. 2012. https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+topics/medicines+and+drugs/clozapine Accessed 20 Nov 2018.
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). National opioid pharmacotherapy statistics (NOPSAD) 2016. https://www.aihw.gov.au/about-our-data/our-data-collections/nopsad-collection Accessed 22 Nov 2018.
   Google Scholar
• Fraser S, Valentine K, Treloar C, Macmillan K. Methadone maintenance treatment in New South Wales and Victoria: takeaways, diversion and other key issues; 2007.
   Google Scholar
• Fonseca J, Chang A, Chang F. Perceived barriers and facilitators to providing methadone maintenance treatment among rural community pharmacists in southwestern Ontario. J Rural Health. 2018;34(1):23–30. https://doi.org/10.1111/jrh.12264.
   PubMed Web of Science ®Google Scholar
• Hammett TM, Phan S, Gaggin J, Case P, Zaller N, Lutnick A, et al. Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries. BMC Health Serv Res. 2014;14(1):261. https://doi.org/10.1186/1472-6963-14-261.
   PubMedGoogle Scholar
• Watson T, Hughes C. Pharmacists and harm reduction: a review of current practices and attitudes. Can Pharm J (Ott). 2012;145(3):124–127 e122. 10.3821/145.3.cpj124.
   PubMedGoogle Scholar
• Winstock AR, Lea T, Sheridan J. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia. Addiction. 2010;105(2):335–342. https://doi.org/10.1111/j.1360-0443.2009.02774.x.
   PubMed Web of Science ®Google Scholar
• Matheson C, Bond CM, Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? Addiction. 2002;97(11):1405–1411.
   PubMed Web of Science ®Google Scholar
• Matheson C, Bond CM, Mollison J. Attitudinal factors associated with community pharmacists’ involvement in services for drug misusers. Addiction. 1999;94(9):1349–1359.
   PubMed Web of Science ®Google Scholar
• Luty J, Kumar P, Stagias K. Stigmatised attitudes in independent pharmacies associated with discrimination towards individuals with opioid dependence. Psychiatrist. 2010;34(12):511–514. https://doi.org/10.1192/pb.bp.109.028951.
   Google Scholar
• Corrigan PW. Mental health stigma as social attribution: implications for research methods and attitude change. Clin Psychol Sci Pract. 2000;7(1):48–67. https://doi.org/10.1093/clipsy.7.1.48.
   Web of Science ®Google Scholar
• Griffiths K. Consumer and carer experiences of stigma from mental health and other health professionals. 2011. https://mhaustralia.org/sites/default/files/imported/component/rsfiles/stigma/Consumer_and_Carer_Experiences_of_Stigma_from_Mental_Health_and_Other_Health_Professionals.pdf Accessed 22 Nov 2018.
   Google Scholar
• Stuart H. Reducing the stigma of mental illness. Glob Ment Health (Camb). 2016;3 e17. 10.1017/gmh.2016.11.
   Google Scholar
• Carr Wendy, Wei Yifeng, Kutcher Stan, Heffernan Amy. Preparing for the Classroom: Mental Health Knowledge Improvement, Stigma Reduction and Enhanced Help-Seeking Efficacy in Canadian Preservice Teachers. 2017.
   Google Scholar
• Morgan AJ, Ross A, Reavley NJ. Systematic review and meta-analysis of mental Health first aid training: effects on knowledge, stigma, and helping behaviour. PLoS One. 2018;13(5):e0197102. https://doi.org/10.1371/journal.pone.0197102.
   Web of Science ®Google Scholar